Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$11.30
+4.53%
Mkt Cap $813.95M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+236.4%
Consensus $38.00 vs current $11.30
NASDAQ·Healthcare·Biotechnology
$11.30
+4.53%
Mkt Cap $813.95M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+236.4%
Consensus $38.00 vs current $11.30